(Q77787318)
Statements
A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes (English)
Italian Cooperative Study Group for rHuEpo in Myelodysplastic Syndromes
P R Ferrini
A Grossi
A M Vannucchi
G Barosi
R Guarnone
N Piva
P Musto
1 December 1998